HPS Pharmacies wish to give notice that Amdipharm Mercury Australia is experiencing a supply interruption for tranylcypromine tablets as follows:
Tranylcypromine (as sulfate) 10mg
Normal supplies are expected to resume in early November 2019. An internationally registered brand of tranylcypromine tablets has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. While Parnate® is presented as a blister pack of 50 tablets, the Section 19A alternative is supplied as a bottle of 100 tablets.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Amdipharm Mercury Australia on 1800 627 680, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates